Genenta Science SPA
NASDAQ:GNTA

Watchlist Manager
Genenta Science SPA Logo
Genenta Science SPA
NASDAQ:GNTA
Watchlist
Price: 5.01 USD -6.53% Market Closed
Market Cap: 91.6m USD
Have any thoughts about
Genenta Science SPA?
Write Note

Intrinsic Value

GNTA's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one GNTA stock under the Base Case scenario is 1.07 USD. Compared to the current market price of 5.01 USD, Genenta Science SPA is Overvalued by 79%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GNTA Intrinsic Value
1.07 USD
Overvaluation 79%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Genenta Science SPA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
GNTA
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for GNTA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about GNTA?
Bearish
Neutral
Bullish

Fundamental Analysis

5.01 USD
-6.53%
-6.53%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Genenta Science SPA
IT
Biotechnology
Market Cap
91.6m USD
IPO
Dec 15, 2021
Employees
4
Italy
Market Cap
91.6m USD
Industry
Biotechnology
IPO
Dec 15, 2021
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Genenta Science SPA

Provide an overview of the primary business activities
of Genenta Science SPA.

What unique competitive advantages
does Genenta Science SPA hold over its rivals?

What risks and challenges
does Genenta Science SPA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genenta Science SPA.

Provide P/S
for Genenta Science SPA.

Provide P/E
for Genenta Science SPA.

Provide P/OCF
for Genenta Science SPA.

Provide P/FCFE
for Genenta Science SPA.

Provide P/B
for Genenta Science SPA.

Provide EV/S
for Genenta Science SPA.

Provide EV/GP
for Genenta Science SPA.

Provide EV/EBITDA
for Genenta Science SPA.

Provide EV/EBIT
for Genenta Science SPA.

Provide EV/OCF
for Genenta Science SPA.

Provide EV/FCFF
for Genenta Science SPA.

Provide EV/IC
for Genenta Science SPA.

Show me price targets
for Genenta Science SPA made by professional analysts.

What are the Revenue projections
for Genenta Science SPA?

How accurate were the past Revenue estimates
for Genenta Science SPA?

What are the Net Income projections
for Genenta Science SPA?

How accurate were the past Net Income estimates
for Genenta Science SPA?

What are the EPS projections
for Genenta Science SPA?

How accurate were the past EPS estimates
for Genenta Science SPA?

What are the EBIT projections
for Genenta Science SPA?

How accurate were the past EBIT estimates
for Genenta Science SPA?

Compare the revenue forecasts
for Genenta Science SPA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genenta Science SPA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genenta Science SPA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genenta Science SPA compared to its peers.

Compare the P/E ratios
of Genenta Science SPA against its peers.

Discuss the investment returns and shareholder value creation
comparing Genenta Science SPA with its peers.

Analyze the financial leverage
of Genenta Science SPA compared to its main competitors.

Show all profitability ratios
for Genenta Science SPA.

Provide ROE
for Genenta Science SPA.

Provide ROA
for Genenta Science SPA.

Provide ROIC
for Genenta Science SPA.

Provide ROCE
for Genenta Science SPA.

Provide Gross Margin
for Genenta Science SPA.

Provide Operating Margin
for Genenta Science SPA.

Provide Net Margin
for Genenta Science SPA.

Provide FCF Margin
for Genenta Science SPA.

Show all solvency ratios
for Genenta Science SPA.

Provide D/E Ratio
for Genenta Science SPA.

Provide D/A Ratio
for Genenta Science SPA.

Provide Interest Coverage Ratio
for Genenta Science SPA.

Provide Altman Z-Score Ratio
for Genenta Science SPA.

Provide Quick Ratio
for Genenta Science SPA.

Provide Current Ratio
for Genenta Science SPA.

Provide Cash Ratio
for Genenta Science SPA.

What is the historical Revenue growth
over the last 5 years for Genenta Science SPA?

What is the historical Net Income growth
over the last 5 years for Genenta Science SPA?

What is the current Free Cash Flow
of Genenta Science SPA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genenta Science SPA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Genenta Science SPA

Balance Sheet Decomposition
Genenta Science SPA

Current Assets 18.6m
Cash & Short-Term Investments 16.9m
Receivables 1.2m
Other Current Assets 441.8k
Non-Current Assets 447.7k
PP&E 62.7k
Other Non-Current Assets 385k
Current Liabilities 2m
Accounts Payable 405.9k
Accrued Liabilities 958.9k
Other Current Liabilities 631.1k
Non-Current Liabilities 204.4k
Other Non-Current Liabilities 204.4k
Efficiency

Earnings Waterfall
Genenta Science SPA

Revenue
0 EUR
Operating Expenses
-9.5m EUR
Operating Income
-9.5m EUR
Other Expenses
526.4k EUR
Net Income
-8.9m EUR

Free Cash Flow Analysis
Genenta Science SPA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

GNTA Profitability Score
Profitability Due Diligence

Genenta Science SPA's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

Genenta Science SPA's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

GNTA Solvency Score
Solvency Due Diligence

Genenta Science SPA's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Genenta Science SPA's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GNTA Price Targets Summary
Genenta Science SPA

Wall Street analysts forecast GNTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GNTA is 23.46 USD with a low forecast of 21.21 USD and a high forecast of 26.25 USD.

Lowest
Price Target
21.21 USD
323% Upside
Average
Price Target
23.46 USD
368% Upside
Highest
Price Target
26.25 USD
424% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GNTA?

Click here to dive deeper.

Dividends

Genenta Science SPA
does not pay dividends
Shareholder Yield

Current shareholder yield for GNTA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one GNTA stock?

The intrinsic value of one GNTA stock under the Base Case scenario is 1.07 USD.

Is GNTA stock undervalued or overvalued?

Compared to the current market price of 5.01 USD, Genenta Science SPA is Overvalued by 79%.

Back to Top